Research Ethics Board
The Research Ethics Board (REB) is comprised of members who among them pool extensive experience and knowledge in scientific investigations, cancer research, patient experience, and the ethical/legal issues raised by research involving humans.
- Chair: Dr. Karen Gelmon
- Vice-chair: Dr. Vivien Bramwell
- List 89: Sept 16, 2024.pdf
- List 88: August 23, 2024.pdf
- List 87: June 18, 2024.pdf
- List 86: April 8, 2024.pdf
- List 85: Sept 12, 2023.pdf
- List 84: July 24,_2023.pdf
- List 83: April 18, 2023.pdf
- List 82: Dec 12, 2022.pdf
- List 81: Oct 20, 2022.pdf
- List 80: Sept 20, 2022.pdf
- List 79: Aug 15, 2022.pdf
- List 78: July 20, 2022.pdf
The REB complies with the US Department of Health and Human Services (DHHS) Code of Federal Regulations (45 CFR 46.103). These regulations state that every institution engaged in human subject research supported or conducted by the DHHS must have assurance of compliance approved by the US Office for Human Research Protections (OHRP/FDA.)
Federalwide Assurance (FWA) and Institutional Review Board (IRB) assurances with OHRP/FDA have been obtained for both BC Cancer and the BC Cancer Research Ethics Board (REBs in Canada are referred to as IRBs in the US):
- Type of Assurance: Federalwide Assurance for "BC Cancer"
- Assurance Numbers: FWA00001149
- Expiry Date: December 12, 2026
- Type of Assurance: IRB Assurance for "B.C. Cancer IRB #1"
- Assurance Numbers: IRB00003797
- Expiry Date: December 27, 2024
The BC Cancer Research Ethics Board is a UBC-affiliated REB. UBC Office of Research Services provides regulatory oversight for all UBC affiliated REBs. Read the Assurance of Compliance Statement.
